XT
CYT

XTX Topco’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

XTX Topco’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,596
Closed -$32.2K – 2475
2023
Q4 		$32.2K Buy
+10,596
New +$32.1K 0.01% 1298

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

XTX Topco's CYT Position: Q1 2024 in Review

XTX Topco sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 10,596 shares — an estimated $32.2K sold.

XTX Topco first reported a position in CYT in Q4 2023 and held it in 1 quarter. The position peaked at $32.2K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • XTX Topco reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • XTX Topco sold 10,596 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $32.2K.
  • XTX Topco first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • XTX Topco's Cyteir Therapeutics, Inc. Common Stock position peaked at $32.2K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.